Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Aug;108(31-32):532-40.
doi: 10.3238/arztebl.2011.0532. Epub 2011 Aug 8.

Hemoglobinopathies: clinical manifestations, diagnosis, and treatment

Elisabeth Kohne  1
Affiliations

Hemoglobinopathies: clinical manifestations, diagnosis, and treatment

Elisabeth Kohne. Dtsch Arztebl Int. 2011 Aug.

Abstract

Background: Hemoglobinopathies are among the most common inherited diseases around the world. They have become much more common recently in northern and central Europe, including Germany, due to immigration.

Method: Selective review of the literature with consideration of national guidelines.

Results: The hemoglobinopathies encompass all genetic diseases of hemoglobin. They fall into two main groups: thalassemia syndromes and structural hemoglobin variants (abnormal hemoglobins). α- and β-thalassemia are the main types of thalassemia; the main structural hemoglobin variants are HbS, HbE and HbC. There are many subtypes and combined types in each group. The highly variable clinical manifestations of the hemoglobinopathies range from mild hypochromic anemia to moderate hematological disease to severe, lifelong, transfusion-dependent anemia with multiorgan involvement. Stem-cell transplantation is the preferred treatment for the severe forms of thalassemia. Supportive, rather than curative, treatment consists of periodic blood transfusions for life, combined with iron chelation. Drugs to treat the symptoms of sickle-cell disease include analgesics, antibiotics, ACE inhibitors and hydroxyurea. Blood transfusions should be given only when strictly indicated. More than 90% of patients currently survive into adulthood. Optimally treated patients have a projected life span of 50 to 60 years.

Conclusion: Hemoglobinopathies are a public health issue in today's multiethnic German population. Adequate care of the affected patients requires a wide variety of diagnostic and therapeutic measures.

PubMed Disclaimer

Figures

eFigure
eFigure
Indications for DNA testing Hb abnormalities: To identify rare abnormalities; for clarification in the absence of electrophoretic or chromatographic separation; as part of genetic enquiries (families, partners, prenatal diagnosis); mixed forms of more than one hemoglobinopathy. Thalassemias: To determine the genetic type of β-thalassemia major; molecular diagnosis of β-thalassemia intermedia; mixed forms of hemoglobinopathy; suspected silent β-thalassemia gene carriers; diagnosis of α-thalassemias; as part of genetic enquiries (families, partners, prenatal diagnosis). RBC, red blood cell
See this image and copyright information in PMC

Comment in

References

    1. Weatherall DJ. Hemoglobinopathies worldwide: Present and future. Curr Mol Med. 2008;8:592–599. - PubMed
    1. Kleihauer E, Kohne E, Kulozik AE. Anomale Hämoglobine und Thalassämie-Syndrome Grundlagen und Klinik. Landsberg: Ecomed Verlagsgesellschaft; 1996.
    1. Steinberg MH, Forget BG, et al., editors. Disorders of hemoglobin: genetics, pathophysiology and clinical management. Cambridge University Press; 2001.
    1. Kulozik AE. Hemoglobinopathies are on the increase. Dtsch Arztebl Int. 2010;107:63–64. - PMC - PubMed
    1. Weatherall DJ, Clegg JB. The thalassaemia syndromes. 4th Edition. Oxford: Blackwell Science Ltd; 2001.

MeSH terms